BE905957A - Nouveau facteur pour la regulation de la croissance cellulaire. - Google Patents

Nouveau facteur pour la regulation de la croissance cellulaire.

Info

Publication number
BE905957A
BE905957A BE0/217546A BE217546A BE905957A BE 905957 A BE905957 A BE 905957A BE 0/217546 A BE0/217546 A BE 0/217546A BE 217546 A BE217546 A BE 217546A BE 905957 A BE905957 A BE 905957A
Authority
BE
Belgium
Prior art keywords
cell growth
human
regulating cell
cultured
new factor
Prior art date
Application number
BE0/217546A
Other languages
English (en)
French (fr)
Original Assignee
Oncogen Soc En Commandite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen Soc En Commandite filed Critical Oncogen Soc En Commandite
Publication of BE905957A publication Critical patent/BE905957A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BE0/217546A 1985-12-20 1986-12-17 Nouveau facteur pour la regulation de la croissance cellulaire. BE905957A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26

Publications (1)

Publication Number Publication Date
BE905957A true BE905957A (fr) 1987-06-17

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217546A BE905957A (fr) 1985-12-20 1986-12-17 Nouveau facteur pour la regulation de la croissance cellulaire.

Country Status (29)

Country Link
JP (1) JP2559035B2 (sv)
KR (1) KR920005920B1 (sv)
CN (1) CN1017626B (sv)
AT (1) AT400444B (sv)
AU (2) AU601168B2 (sv)
BE (1) BE905957A (sv)
CA (1) CA1340296C (sv)
CH (1) CH675727A5 (sv)
CY (1) CY1608A (sv)
DE (2) DE3643428A1 (sv)
DK (1) DK174094B1 (sv)
ES (1) ES2003180A6 (sv)
FI (1) FI91484C (sv)
FR (1) FR2597108B1 (sv)
GB (1) GB2185485B (sv)
GR (1) GR862936B (sv)
HK (1) HK65691A (sv)
HU (1) HU210694B (sv)
IE (1) IE59415B1 (sv)
IL (1) IL81017A (sv)
IT (1) IT1213428B (sv)
LU (1) LU86718A1 (sv)
NL (1) NL8603209A (sv)
NO (1) NO174556C (sv)
NZ (1) NZ218634A (sv)
OA (1) OA08494A (sv)
PT (1) PT83986B (sv)
SE (1) SE505059C2 (sv)
SG (1) SG60891G (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Monoclonal antibodies against oncostatin M, their preparation and pharmaceutical preparations containing them
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
NO174556C (no) 1994-05-25
LU86718A1 (fr) 1988-07-14
ATA340686A (de) 1995-05-15
JP2559035B2 (ja) 1996-11-27
SE8605459D0 (sv) 1986-12-18
IE863345L (en) 1987-06-20
DE3645095C2 (de) 1993-11-18
HU210694B (en) 1995-06-28
GR862936B (en) 1987-10-28
FI91484B (sv) 1994-03-31
SE505059C2 (sv) 1997-06-16
ES2003180A6 (es) 1988-10-16
CN86108955A (zh) 1987-12-02
GB8629997D0 (en) 1987-01-28
JPS62236498A (ja) 1987-10-16
GB2185485B (en) 1990-07-04
CN1017626B (zh) 1992-07-29
AU6660886A (en) 1987-06-25
NO865178D0 (no) 1986-12-19
HUT43103A (en) 1987-09-28
IL81017A (en) 1993-01-14
FI865156A (sv) 1987-06-21
FI865156A0 (sv) 1986-12-17
HK65691A (en) 1991-08-23
KR870005645A (ko) 1987-07-06
IL81017A0 (en) 1987-03-31
NO174556B (no) 1994-02-14
DK615386A (da) 1987-06-21
AU6776590A (en) 1991-03-14
OA08494A (fr) 1988-07-29
DE3643428C2 (sv) 1990-08-23
SG60891G (en) 1991-08-23
PT83986A (en) 1987-01-01
KR920005920B1 (ko) 1992-07-24
DE3643428A1 (de) 1987-09-24
DK174094B1 (da) 2002-06-10
NZ218634A (en) 1991-06-25
FI91484C (sv) 1994-07-11
AU639048B2 (en) 1993-07-15
NL8603209A (nl) 1987-07-16
AT400444B (de) 1995-12-27
GB2185485A (en) 1987-07-22
CH675727A5 (sv) 1990-10-31
PT83986B (pt) 1989-07-31
IT8622787A0 (it) 1986-12-19
CA1340296C (en) 1998-12-29
IT1213428B (it) 1989-12-20
DK615386D0 (da) 1986-12-18
FR2597108A1 (fr) 1987-10-16
NO865178L (no) 1987-06-22
AU601168B2 (en) 1990-09-06
IE59415B1 (en) 1994-02-23
CY1608A (en) 1992-04-03
FR2597108B1 (fr) 1991-02-15
SE8605459L (sv) 1987-06-21

Similar Documents

Publication Publication Date Title
Bartram et al. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia
ATE153382T1 (de) Rekombinantes dns-verfahren und wirtszellen
MX9800556A (es) Secuencia aislada de adn para el uso como una region reguladora en un gen quimerico util para la transformacion de plantas.
EP0176588A4 (en) THROMBOCYTE-LIKE GROWTH REGULATOR.
ZA857824B (en) Substituted propane-phosphonous acid compounds
BE905957A (fr) Nouveau facteur pour la regulation de la croissance cellulaire.
DE69333079D1 (de) Expressionskassette und plasmid für eine expression spezifisch für schliesszellen und ihre verwendung zur einführung in transgene pflanzenzellen und pflanzen
Berg et al. Increased protein binding to a− 530 mutation of the human β‐globin gene associated with decreased β‐globin synthesis
DE3660021D1 (en) Plant for the anaerobic purification of waste water
KR890700672A (ko) 혈소판과 관계된 생장조절제
ATE86635T1 (de) Reinigung von rekombinantem interleukin-1.
MC2145A1 (fr) Proteine a activite urate oxydase,gene recombinant codant pour celle-ci,vecteur d'expression,micro-organismes et cellules transformees
DE3688671T2 (de) Menschliches Interferon-beta2A ; Vektoren, die Gene enthalten, die für das genannte Interferon kodieren; Zellinien, die dieses produzieren und Verwendung des genannten Interferons als Pharmazeutikum.
Cox et al. Assignment of the gene for beta 2-microglobulin (B2m) to mouse chromosome 2.
ATE52540T1 (de) Verwendung von glutamin in form seiner di- und tripeptide im naehrmedium fuer zellkulturen.
ES8707565A1 (es) Un procedimiento para producir un anticuerpo monoclonal
SILLETTI et al. Autocrine motility factor-receptor in human bladder-carcinoma-gene-expression, loss of cell-contact regulation and chromosomal mapping
ATE53237T1 (de) Vergroessernde virale dna-segmente.
MacKintosh et al. Proteins synthesized before and after fertilization in sea urchin eggs
KR950701647A (ko) 필리스타타 히베르날리스(Filistata hibernalis)로부터의 칼슘 채널 차단 폴리펩티드(CALCIUM CHANNEL BLOCKING POLYPEPTIDES FROM FILISTATA HIBERNALIS)
ATE90386T1 (de) Verfahren zur expression von genen in hefe, dns- fragmente und plasmide die letztere fragmente enthalten und zur durchfuehrung des verfahrens verwendet werden.
KR950704352A (ko) 테라포시데 아포노펠마로부터의 칼슘 통로 차단 폴리펩티드(calcium channel blocking polypeptides from theraphosidae aphonopelma)
Lappin et al. Anaphylatoxins inhibit C2 production.
Ikeda et al. RNA Polymerase in Vegetative Cells of Bacillus subtilis II. New Polypeptide Factors, FI and FII, Stimulating In Vitro RNA Synthesis Directed by Phage M2 DNA
Tamura et al. DNA analysis of a patient with two different marker chromosomes using Y-specific DNA probes

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *ONCOGEN SOC.EN COMMANDITE

Effective date: 20061217